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Abstract
Background: The aim of this study is to point out timing of left atrium and its appendage 
functional recovery after cardioversion (CV) in recent onset atrial fibrillation (AF).
Methods: Fifty patients; 27 within 48-h (group I) and 23 after 48-h (group II), of AF onset, 
who had successful CV underwent transthoracic echocardiography (TTE), before and im-
mediately after CV, then 15, 30 and 90 days later. Transesophageal echocardiography (TEE) 
was performed for group II before and for all patients immediately after CV and 1 month later. 
Mitral peak A velocity and left atrial (LA) reversal (Ar) velocity, tissue Doppler imaging (TDI) 
of septal mitral annular velocity (A1) and LA free wall velocity (A3) were recorded. Absence or 
peak A velocity < 50 cm/s was taken as a cut off value for atrial stunning. Intra-atrial conduc-
tion time (IACT) was measured. LA appendage late emptying (LAALE) velocity was measured 
by TEE-pulsed TDI of LA appendage.
Results: Post CV, all group II and 34% of group I experienced stunning. In both groups, peak 
A, Ar, A1, A3 and LAALE velocities increased (p = 0.000), while IACT decreased (p = 0.000) 
progressively over time. Partial recovery occurred after 15 and 30 days, while full recovery oc-
curred 30 and 90 days post CV in groups I and II, respectively. IACT1 and IACT2 correlated 
with LA diameter (r = 0.2778 and r = 0.227, respectively, p < 0.01).
Conclusions: Stunning and functional recovery of the LA and its appendage are strongly 
determined by the duration being in AF. Serial IACT by TDI was a good new parameter for 
detection of functional recovery of LA and LA appendage. (Cardiol J 2015; 22, 6: 699–707)
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Introduction
Successful cardioversion of atrial fibrillation 
(AF) usually results in left atrial (LA) and LA ap-
pendage (LAA) stunning that may last up to a few 
weeks, observed after all methods of cardioversion 
(CV). It is responsible for the increased incidence 
of thrombus formation and embolic events after CV, 
despite restoration of sinus rhythm [1].
Both, mitral A-wave velocity and LA empty-
ing fraction (among other parameters) are derived 
by conventional transthoracic echocardiography 
(TTE) to evaluate the contractile function of the 
LA. Tissue Doppler imaging (TDI) can provide 
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other parameters of LA function such as A’ velocity 
at different segments of the atria and intra-atrial 
conduction time (IACT) [2].
Transesophageal echocardiography (TEE) 
remains a semi-invasive procedure, limiting its 
serial application as a screening tool. Therefore, it 
is desirable to obtain information regarding LAA 
function by TTE [3]. Evaluation of the LA wall us-
ing pulsed TDI is feasible and reproducible. TDI 
provides a useful method in the assessment of LA 
conduction times [4]. The mitral annular velocities, 
obtained by transthoracic TDI are useful predictors 
for LA dysfunction and thrombus formation [5].
Aim of the study is to point out timing of LA 
and LAA functional recovery after CV in recent 
onset AF.
Methods
Fifty consecutive patients with recent onset 
non-valvular AF who underwent successful CV 
to sinus rhythm were enrolled in the study to be 
followed up for 3 months, after exclusion of those 
with chronic AF, valvular heart disease, reversible 
causes of AF, patients with liver impairment and 
structural heart disease and those with LA and/or 
LAA thrombus in initial TEE.
The patients were divided into two groups: 
Group I — 27 patients with recent AF (within 48 h) 
and underwent successful CV and maintained sinus 
rhythm; Group II — 23 patients with recent onset 
AF (after 48 h) and underwent successful CV and 
maintained sinus rhythm.
Approval was obtained from the Ethics Com-
mittee of our Cardiology Department after approval 
of the Institutional Review Board.
After giving a written informed consent, all 
participants were subjected to the following:
 — full history taking stressed on age, duration 
of AF, past history of hypertension, ischemia 
or diabetes;
 — thorough clinical examination with stress on 
heart rate, blood pressure and signs of left 
ventricular (LV) failure;
 — resting 12-lead surface electrocardiography 
(ECG): to confirm rhythm and rate;
 — TTE, by an (Hewlett Pakard SONOS 5500) 
echo-set and 2.5-MHz transducers were used 
for imaging and Doppler studies. Patients were 
examined in the left lateral decubitus position 
after resting for 30 min, every patient was 
examined: before CV, immediately after (av-
erage 1 day), 15 days, 1 month, and 3 months 
after CV. The following measurements were 
taken according to the recommendations of 
the American Society of Echocardiography 
and averaged from 3 cardiac cycles; ECG was 
obtained simultaneously.
Pulsed wave (PW) Doppler study. In the 
apical 4-chamber view, the following measure-
ments were recorded.
Peak transmitral A wave velocity. The 
sample volume was positioned at the tips of the 
mitral valve leaflets, absence or peak A wave 
velocity less than 50 ms is taken as a cut off value 
denoting atrial stunning after CV [6].
Pulmonary venous flow pattern. The sam-
ple volume was positioned in the right upper pul-
monary vein. The atrial reversal Ar velocity was 
measured. Two-dimensional (2D) echocardio-
graphy: To assess the LV function: Using modified 
Simpson’s rule. LA diameter was also measured. 
TDI: Tissue Doppler echocardiography was per-
formed by adjusting the spectral pulsed Doppler 
signal filters until a Nyquist limit of 15–20 cm/s, 
using the minimal optimal gain, monitor flow ve-
locity was adjusted to 50–100 mm/s to optimize 
the images of the myocardial velocity to measure 
the following:
Mitral annular velocities were measured 
from the apical 4-chamber view with the pulsed 
wave sample volume placed at septal (A1) and 
lateral (A2) mitral annular tissues.
IACT is the total duration of electrical activity 
of the LA in 1 cardiac cycle (the time between right 
atrial and LA activation). It was measured from the 
onset of P wave in ECG to the onset of A’ wave 
(PA) at both septal (IACT1) and lateral (IACT2) 
aspects of mitral annulus.
TEE was conducted using the same machine 
equipped with multi-plane transesophageal probe 
(5 mHz). Images were taken before CV for patients 
with recent AF more than 48 h and for all patients; 
immediately after, and then 1 month later. To visu-
alize the LAA from the mid-esophageal position, 
the angle providing the longest apex to orifice 
length was used for pulsed Doppler analysis, typi-
cally between 45 and 90. A 4 mm sample volume 
was positioned 1 cm from the LAA orifice. Pulsed 
Doppler was used to measure the LAA flow and 
LAA late emptying (LAALE) velocities. In the TDI 
records, the first positive wave after the P wave 
(in ECG) was accepted as LAALE.
LA spontaneous echo contrast severity, graded 
on a scale of 0–4.
Off-line assessment of 2D, Doppler, TDI and 
TEE images was performed by 2 investigators who 
were blinded to clinical data; the assessment was 
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performed in 2 separate occasions for each of the 
investigators.
Electrical or pharmacological CV. The 
cases were selected for treatment designed to re-
store and maintain normal sinus rhythm according 
to the ACC/AHA/HRS guidelines [7].
Direct current cardioversion. Synchronized 
CV was performed during deep sedation with intra-
venous midazolam delivering a stepwise sequence 
of biphasic shocks as follows: first attempt at 100 
Joules (J); if failed a second one at 150 J; if failed 
a third at 200 J; if failed a final of 200 J, with its fail-
ure considered an unsuccessful attempt. Patients 
who were cardioverted are maintained on amiodar-
one at a dose of 800 mg per day in divided dose until 
10 g total, then 200 mg per day as maintenance.
Pharmacological CV: Patients with re-
cent-onset AF without contraindications for the 
propafenone or amiodarone were treated either 
with:
 — oral propafenone (600 mg for the first 24 h 
and if necessary a repeated dose of 300 mg for 
24 h) then 450 to 900 mg daily oral dose for 
maintenance of sinus rhythm or;
 — amiodarone (intravenous) 5 to 7 mg/kg over 
30 to 60 min, then 1.2 to 1.8 g per day continu-
ous IV until 10 g total, then 200 to 400 mg per 
day oral maintenance.
Statistical analysis
All data were analyzed using SPSS 16 (SPSS, 
Inc. Chicago, IL, USA). Results were presented as 
mean value ± standard deviation for continuous 
variables and as frequency (%) for categorical vari-
ables. Means were compared using independent 
t-test. Categorical data were compared using 
c2 test, for repeated measures one way (ANOVA) 
was performed to estimate within patient changes 
for detection of LA and LAA stunning and function-
al recovery in the follow-up. Pearson correlations 
between variables were made. Determination of 
cut off values with associated sensitivity and speci-
ficity was performed using the receiver operating 
characteristics analysis.
Results
Our patients were divided into two groups, 
group I (AF cardioverted within 48 h): included 
27 patients; 18 males and 9 females with mean age 
43.07 ± 4.22 years; group II (AF cardioverted after 
48 h) included 23 patients; 14 males and 9 females 
with mean age 54.17 ± 3.44 years, incidence of 
smoking was more in group II — 12 (52.2%) vs. 
7 (26%) in group I with a statistically significant 
difference (p = 0.05 and so group II has higher 
body mass index 28.15 ± 3.58 vs. 32.9 ± 5.03 with 
a statistically significant difference (p = 0.01), as 
in Table 1.
The serial changes in the different echocar-
diographic parameters as shown in Table 2, were 
as follows: the difference of serial A wave velocity 
of transmitral flow between groups was statisti-
cally significant (p = 0.000). A wave increased 
significantly in a progressively linear trend over 
time from 50.33 ± 5.57 cm/s to full increase at 1 
month — 62.66 ± 3.1 cm/s in group I and from 29.6 
± 4.85 cm/s to 59.6 ± 3.5 cm/s after 3 months in 
Table 1. Patients’ characteristics.
Variables Group I: CV before 48 h  
(n = 27)
Group II: CV after 48 h  
(n = 23)
P 
Age [years] 43.07 ± 4.22 54.17 ± 3.44 0.125
Gender: 0.67
Male 18 (66.7%) 14 (60.9%)
Female 9 (33.3%) 9 (39.1%)
Smokers 7 (26%) 12 (52.2%) 0.05
Body mass index 28.15 ± 3.58 32.9 ± 5.03 0.001
AF duration [h] 8.52 ± 3.04 71.3 ± 12.7 0.000
Electrical CV 12 (44.4%) 12 (52.2%) 0.809
Pharmacological CV 15 (55.6%) 11 (47.8%) 0.765
Amiodarone 9 (33.3%) 6 (26.1%) 0.821
Propafenone 6 (22.2%) 5 (21.7%) 0.809
AF — atrial fibrillation; CV — cardioversion; p > 0.05 indicates non-significance, p < 0.05 indicates significance and p < 0.01 indicates high 
significance
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Table 2. Serial echocardiographic parameters.
Variables Group I (n = 27)
Mean ± SD
Group II (n = 23)
Mean ± SD
P
Left ventricular ejection fraction [%]
Immediately after
After 15 days
After 1 month
After 3 months
61.65 ± 2.44
61.65 ± 2.44
61.96 ± 2.34
61.65 ± 2.44
58.74 ± 2.11
58.82 ± 1.99
59.08 ± 2.06
59.13 ± 2.02
0.000
LA diameter [mm]
Immediately after
After 15 days
After 1 month
After 3 months
35.56 ± 2.31
35.56 ± 2.31
34.81 ± 2.32
34.8 ± 2.32
39.30 ± 1.79
39.30 ± 1.79
39.30 ± 1.79
38.3 ± 1.79
0.000
A wave velocity after CV [cm/s]
Immediately after
After 15 days
After 1 month
After 3 months
50.33 ± 5.57
57.40 ± 3.68
62.66 ± 3.1
62.66 ± 3.14
29.6 ± 4.85
41.47 ± 2.98
52.56 ± 2.57
56.04 ± 1.71
0.000
PV Ar velocity after CV [cm/s]
Immediately after
After 15 days
After 1 month
After 3 months
22.85 ± 2.07
25.33 ± 2.21
27.92 ± 2.68
27.92 ± 2.63
19.08 ± 1.41
22.04 ± 1.58
25 ± 1.8
27.21 ± 1.34
0.000
A1 wave velocity after CV [cm/s]
Immediately after
After 15 days
After 1 month
After 3 months
7.67 ± 1.56
8.68 ± 1.22
9.6 ± 0.9
9.6 ± 0.9
4.09 ± 1.56
5.65 ± 0.93
7.22 ± 0.85
8.46 ± 0.54
0.000
A3 wave velocity after CV [cm/s]
Immediately after
After 15 days
After 1 month
After 3 months
8.36 ± 1.36
9.5 ± 1.1
10.46 ± 0.98
10.46 ± 0.98
4.17 ± 0.78
5.81 ± 0.95
7.38 ± 0.97
8.63 ± 0.72
0.000
IACT1 after CV [ms]
Immediately after
After 15 days
After 1 month
After 3 months
96.3 ± 7.52
88.48 ± 7.01
80.52 ± 8.34
80.52 ± 8.31
112.4 ± 9.52
104.21 ± 7.7
95.65 ± 5.27
90 ± 4.4
0.000
IACT2 after CV [ms]
Immediately after
After 15 days
After 1 month
After 3 months
96.44 ± 6.68
88.52 ± 7
79.78 ± 8.36
79.78 ± 8.36
111.74 ± 24.01
106.26 ± 7.77
97.08 ± 5.42
91.04 ± 4.49
0.000
LAA emptying velocity [cm/s]
Immediately after CV
After 1 month
38.74 ± 2.7
46.70 ± 1.43
19.56 ± 2.84
40.17 ± 3.25 0.000
LAA emptying velocity by TDI [cm/s]
Immediately after CV
After 1 month
9.94 ± 1
13.02 ± 0.62
4.51 ± 0.62
10.1 ± 0.85 0.000
Spontaneous echo contrast grading
Immediately
After 1 month
0
0
1.04 ± 0.47
0.02 ± 0.14
0.000
0.566
CV — cardioversion; LA — left atrial; LAA — left atrial appendage; A wave — peak late diastolic mitral flow; A1 — septal mitral annular A’  
(by tissue Doppler); A3 — left atrial mid free wall A’; IACT1 — septal mitral annular intra-atrial conduction time; IACT2 — lateral mitral annular 
intra-atrial conduction time; PV Ar — pulmonary venous flow-left atrial flow reverse; TDI — tissue Doppler imaging
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group II. Pulmonary Ar velocity increased progres-
sively in a linear trend over time from 22.85 ± 
± 2.07 cm/s to full increase at 1 month — 27.92 ± 
± 2.68 cm/s in group I and from 19.08 ±1.41 cm/s 
to 27.21 ± 1.34 cm/s after 3 months in group II with 
a statistically significant difference between the 
groups p = 0.000). The difference of serial septal 
mitral annular A’ wave velocity, by tissue Doppler 
(A1) between groups was statistically significant 
(p = 0.000). A1 wave increased significantly in 
a progressively linear trend over time from 7.67 ± 
± 1.56 cm/s to full increase at 1 month 9.6 ± 0.9 cm/s 
in group I and from 4.09 ± 0.87 cm/s to 8.46 ± 
± 0.54 cm/s after 3 months in group II. LA mid 
free wall A’ (A2) velocity increased progressively 
in a linear trend over time from 8.36 ± 1.36 cm/s 
to full increase at 1 month — 10.46 ± 0.98 cm/s 
in group I and from 4.17 ± 0.78 cm/s to 8.63 ± 
± 0.72 cm/s) after 3 months in group II with 
a statistically significant difference between the 
groups (p = 0.000). The intra-atrial conduction 
time at septal and lateral aspects of the mitral 
valve (IACT1 and IACT2) decreased progressively 
in a linear trend over time from 96.3 ± 7.52 and 
96.44 ± 6.68 ms, respectively, to full reduction 
at 1 month — 80.52 ± 8.3 and 79.78 ± 8.36 ms, 
respectively in group I and from 112.4 ± 9.52 and 
111.74 ± 24.01 ms, respectively to 90 ± 4.4 and 
91.04 ± 4.49 ms, respectively after 3 months in 
group II with a statistically significant difference 
between groups (p = 0.000). Both LAA emptying 
Doppler and TDI estimated velocities increased 
significantly from 38.74 ± 2.73 and 9.94 ± 1 cm/s, 
respectively immediately after CV to 46.70 ± 1.43 
and 13.02 ± ± 0.62 cm/s, respectively at 1 month in 
group I, it decreased significantly immediately post 
CV to be 19.56 ± 2.84 and 4.51 ± 0.62 cm/s, re-
spectively and increased significantly to be 40.17 ± 
± 3.25 and 10.1 ± 0.85 cm/s, respectively at 
1 month in group II, with a statistically significant 
difference between groups (p = 0.000).
LA diameter decreased progressively in a lin-
ear trend over time from 35.56 ± 2.31 mm to full 
reduction at 1 month — 34.81 ± 2.32 mm in group I 
and from 39.30 ± 1.79 mm to 38.3 ± 1.79 mm after 
3 months in group II with a statistically significant 
difference between the groups (p = 0.000).
There was no spontaneous echo contrast 
(SEC) in group I either immediately after or after 
1 month of CV, but it was found in group I (grade 
1.04 ± 0.47) immediately after CV and improved 
by the end of 1st month to be (grade 0.02 ± 0.14).
AF duration correlated negatively with: 
A wave velocity (r = –0.888, p = 0.000), A1 
(r = –0.786, p = 0.000), A3 (r = –0.868, p = 0.000), 
pulmonary venous flow-LA flow reverse (r = –0.712, 
p = 0.000), LAA emptying velocity (r = –0.962, 
p = 0.000) and LAA emptying velocity by tissue 
Doppler (r = –0.947, p = 0.000) and positively with: 
IACT1 (r = 0.708, p = 0.000) and IACT2 (r = 0.474, 
p = 0.001).
LA diameter correlated significantly with 
IACT1 (r = 0.277, p = 0.000) and IACT2 (r = 0.227, 
p = 0.001).
The increase of the A1 velocity to 8 cm/s re-
flected a cut off value with a sensitivity of 93.9% 
and specificity of 41.2% (p = 0.002), A2 at 8.5 cm/s 
reflected a cut off value with a sensitivity of 87.9% 
and specificity of 41.2% (p = 0.019). The IACT 
at septal annular velocity (IACT1) at 98.5 cm/s 
reflected a cut off value with a sensitivity of 72.7% and 
a specificity of 58.8% (p = 0.029), while the IACT at 
lateral annular velocity (IACT2) at 98.5 cm/s reflected 
a cut off value with a sensitivity of 72.7%, a specificity 
of 47.1% (p =0.162).LAA emptying velocity at a cut 
off value of 38.5 cm/s had a sensitivity of 87.9% and 
specificity of 52.9% (p = 0.002), but by TDI at a veloc-
ity of 10 cm/s it reflected a cut off value with a sensi-
tivity of 87.9% and a specificity of 70.6% (p = 0.000) 
(Figs. 1–4).
Discussion
Mechanical dysfunction of the LA and/or LAA, 
called atrial stunning, develops after successful CV 
of AF or atrial flutter. Its prevalence varies from 
38% to 80% in the previous studies [8]. In fact, 
atrial stunning is no more than a continuation of 
atrial remodeling that occurs during AF. It is char-
acterized by progressive structural changes of the 
atria, especially with longer duration of arrhythmia 
[9]. Atrial stunning was defined as the presence of 
any of the following parameters: (1) Absence or 
peak velocity < 50 cm/s of mitral inflow A-wave, 
(2) Recently developed of SEC or thrombus, or 
increase in severity of the already existing SEC, 
(3) LAA emptying velocity < 20 cm/s, and (4) De - 
crease of 20% in peak LAA emptying velocity 
after CV. After successful CV of AF, if the patient 
had at least one of above 4 parameters, they were 
described as having stunning [10].
Lack of effective atrial contractility can lead to 
hemodynamic changes, which may result in throm-
bus formation, with subsequent thromboembolic 
events [11].
Several investigators have evaluated the 
recovery of atrial function with restoration of 
sinus rhythm using invasive and non-invasive 
www.cardiologyjournal.org 703
Ahmed S. Ammar et al., Left atrial stunning and atrial fibrillation
Figure 1. Serial changes of A wave after cardioversion of atrial fibrillation.
Figure 2. Serial changes of intra-atrial conduction time 1 (IACT1) after cardioversion of atrial fibrillation.
techniques, these studies confirmed the electro-
mechanical dissociation of atrial recovery after 
successful CV [12] with a delay in the gradual 
improvement of the atrial mechanical function [13].
We investigated the serial echocardiographic 
parameters for detection of both stunning duration 
and timing of recovery of LA and LAA function post 
cardioversion of recent AF.
In our study, smoking and obesity were more 
prevalent among patients with longer duration of 
AF before CV, which may be due to earlier presen-
tation of non obese and non smokers as the LA is 
smaller and so pulmonary congestion and dyspnea, 
as an alarming sign, was presented earlier, in agree-
ment with Gami et al. [14].
Firstly, we decided to follow-up the param-
eters of LA function immediately post CV (aver-
age 1 day). We found that the transmitral A wave 
and pulmonary venous flow (Ar) velocities were 
lower in patients cardioverted after 48 h (with 
longer duration being in AF), representing more 
stunning and in this group of patients they showed 
delayed recovery to be completed after 3 months, 
but complete recovery in group I after 1 month. 
Manning et al. [5], Ciolli et al. [15] and Dogan et 
al. [8] agreed with us. Only 34% of our patients (in 
group I) showed complete recovery of mechanical 
function immediately after CV similar to these in 
published reports (ranging from 38% to 80%) [1]. 
Harjai et al. [16] found that: many studies stated 
that recovery of effective mechanical function oc-
curs in over 50% of patients 1 day after CV. Hyon et 
al. [17] found that: transmitral A velocity was still 
low (34.9 ± 19.5 cm/s) immediately after sinus con-
version. Wożakowska-Kapłon et al. [18] and Boyd 
et al. [19] found that the maximum improvement in 
atrial contraction occurred in the first month after 
restoration of sinus rhythm. Atrial reversal flow 
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be delayed with a progressive increase in the atrial 
contribution to ventricular filling documented over 
the 3 months following successful CV [20]. Khan 
[21] estimated that duration of preceding AF/atrial 
flutter, atrial size, and underlying heart disease are 
determinants of the extent of atrial stunning, we 
found that LA diameter in group I was higher than 
that of group II.
We found that the mitral annular A (A1) wave 
velocity and the LA free wall velocity by, TDI, were 
lower in patients being longer in AF, and gradually 
increased to be full after 3 months but higher in pa-
tients cardioverted within 48 h and went rapidly to 
recovery to be full after 1 month only. We used it as 
it can provide a more accurate assessment of atrial 
function by measuring intrinsic atrial longitudinal 
contraction [21]. Boyd et al. [19] supported our 
results that TDI could be useful for serial follow-up 
of LA recovery after AF CV.
Our study showed that IACT, representing the 
atrial electromechanical interval, in serial echo, was 
shorter in group I, regained and stabilized in this 
group after 1 month, but longer and showed delayed 
recovery in group II. IACT showed significant cor-
relation with AF duration as the other parameters 
used to estimate stunning and recovery of LA 
and LAA did, and showed significant correlation 
with the LA diameter. IACT may be considered 
a useful follow-up parameter for mechanical re-
covery (electrical-mechanical coupling) detection 
in patients after CV although our patients were on 
propafenone or amiodarone (which are accused to 
prolong the IACT) this factor was equally present in 
both groups. As previous studies showed that, LA 
electromechanical time was significantly prolonged 
in patients with recurring AF [22]. Omi et al. [23] 
found that: in paroxysmal AF group, these intervals 
were significantly longer than in the control group. 
This parameter is affected in patients with parox-
ysmal AF and should be useful for detecting atrial 
impairment related to paroxysmal AF. Acar et al. [24] 
found that: increased inter-atrial electromechanical 
delay might be related with an increased risk for AF.
We found that LAA emptying velocities by Dop-
pler and by TDI, increased significantly over time 
in group I (but we had no idea about it before CV) 
and decreased significantly immediately post CV 
and increased significantly after 1 month in group II. 
Zapolski and Wysokiński [25] and Savontaus and 
Markku [26] estimated that all the atrial append-
age Doppler velocity parameters were significantly 
reduced after the sinus rhythm restoration.
Agmon et al. [27] found that TEE is an invasive 
procedure; sequential TEE data assessing recovery 
Figure 4. Receiver operating characteristics (ROC) analysis 
of validity of serial intra-atrial conduction time 1 (IACT1) 
and 2 (IACT2) in detection of left atrium electromechani-
cal recovery post cardioversion of recent atrial fibrillation.
Figure 3. Receiver operating characteristics (ROC) curve 
of left atrium appendage emptying velocity, velocity at 
cut off value of 38.5 cm/s: had a sensitivity of 87.9%, 
a specificity of 52.9%, a positive predictive value of 78.4%, 
and a negative predictive value of 69.2% (p = 0.002).
represents transient reversal of flow in the pulmo-
nary vein resulting from organized atrial activity. 
The return of atrial contraction has been shown to 
www.cardiologyjournal.org 705
Ahmed S. Ammar et al., Left atrial stunning and atrial fibrillation
of LAA function are limited. Significant improve-
ment has been observed in LAA function within 
7–30 days after CV, although the determinants of 
the time-course of LAA recovery are incompletely 
defined.
Limitations of the study
The present study was limited by the small 
sample size. We selected non valvular patients.
Conclusions
Serial transthoracic IACT at medial and lateral 
mitral annulus, representing the atrial electrome-
chanical interval, by TDI was a good new parameter 
for detection of functional recovery of LA and LAA. 
Also the longer the duration of AF before CV the 
delayed the recovery of LA and LAA mechanical 
function.
Clinical implications: These results may 
have important implications in guiding the appro-
priate duration of anticoagulant therapy after CV 
of recent AF, as we can stop oral anticoagulant if 
LA and LAA functional recovery become full within 
1 month in these cases, with respect to the CHA2DS2- 
-VASc score, that acknowledges the importance 
of age ≥ 75 years as having additional weight as 
a single risk factor for stroke (denoted by a score 
of 2 points) and indicates that age is not a yes–no 
phenomenon because risk of stroke increases with 
age, particularly from 65 years of age on [28, 29].
Recommendation: We recommend serial 
estimation of the LAA empting velocities both 
by Doppler and TDI modalities by TTE, before 
and after CV for longer time. Prospective studies 
should be conducted on a larger group of patients 
who should be categorized into groups according 
to the underlying heart disease. The medication 
history must be kept in mind as some drugs can 
affect the IACT.
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